Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease
- 1 February 1997
- journal article
- Published by Elsevier in The Lancet
- Vol. 349 (9049) , 375-380
- https://doi.org/10.1016/s0140-6736(97)80008-6
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Effects of Carvedilol, a Vasodilator–β-Blocker, in Patients With Congestive Heart Failure Due to Ischemic Heart DiseaseCirculation, 1995
- Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double-blind randomized studyJournal of the American College of Cardiology, 1995
- Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathyJournal of the American College of Cardiology, 1994
- Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: A randomized, double-blind, placebo-controlled studyJournal of the American College of Cardiology, 1994
- Beta-blockers in heart failure: Promising or proved?Journal of the American College of Cardiology, 1994
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Usefulness of bucindolol in congestive heart failureThe American Journal of Cardiology, 1990
- Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale.Circulation, 1981
- Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.Circulation, 1978